Implementation of a Pediatric-to-adult Asthma Transition Program
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01521247|
Recruitment Status : Completed
First Posted : January 30, 2012
Last Update Posted : September 9, 2016
Despite the clear and often stated need, a formal transition program does not exist for asthma patients as they move from pediatric to adult care in Western Canada. This population is not having their health care needs met. The investigators proposed study would evaluate a well structured transition program designed to facilitate continuity of care for this at risk patient population.
Primary hypothesis: A pediatric-to-adult asthma transition program will improve the asthma-specific quality of life of young asthma patients in the Calgary area over a 1 year period.
Secondary hypothesis: A pediatric-to-adult asthma transition program will improve asthma control, decrease asthma exacerbations, and reduce health care utilization in young asthma patients in the Calgary area over a 1 year period.
|Condition or disease||Intervention/treatment||Phase|
|Asthma Education||Other: Asthma Transition Program||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||30 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Study Start Date :||April 2010|
|Actual Primary Completion Date :||July 2014|
|Actual Study Completion Date :||July 2015|
No Intervention: Control group
Asthma Transition Program
Asthma Transition Program
Other: Asthma Transition Program
Other Name: Asthma Education and Referral.
- Asthma Quality of Life Questionnaire with Standardized Activities [AQLQ(S)] [ Time Frame: 12 months ]AQLQ(S) will be recorded at baseline, 6 months, and 12 months. The primary outcome will be the change in AQLQ(S) from baseline to 12 months.
- Asthma Control Questionnaire (ACQ) [ Time Frame: 12 months ]The ACQ will be administered at baseline, 6 months, and 12 months. The secondary outcome will assess change in ACQ from baseline to 12 months.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01521247
|Calgary Regional Pediatric Asthma Clinic|
|Calgary, Alberta, Canada, T3B 6A8|
|Study Director:||Mary Noseworthy, MD||Alberta Children's Hospital|
|Study Director:||Rodel Padua, RRT|
|Study Director:||Sheldon Spier, MD||Alberta Children's Hospital|
|Study Director:||Ward Flemons, MD||University of Calgary|
|Principal Investigator:||Warren Davidson, MD||University of Calgary|